Saeideh Jafarinejad-Farsangi

Dr. Saeideh Jafarinejad-Farsangi

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
ZNZeinab Neisi
Zeinab Neisi
ZAZeinab Ansari-Asl
Zeinab Ansari-Asl
SJSaeideh Jafarinejad-Farsangi
Saeideh Jafarinejad-Farsangi
MTMojdeh Esmaeili Tarzi
Mojdeh Esmaeili Tarzi
TSTahereh Sedaghat
Tahereh Sedaghat
VNValiollah Nobakht
Valiollah Nobakht

1 June 2020 in Toxicology in Vitro
Verified
Journal Article
Closed access
MHMahnaz Sadat Hashemi
Mahnaz Sadat Hashemi
SGSedigheh Gharbi
Sedigheh Gharbi
SJSaeideh Jafarinejad-Farsangi
Saeideh Jafarinejad-Farsangi
ZAZeinab Ansari-Asl
Zeinab Ansari-Asl
ADAmin Shiralizadeh Dezfuli
Amin Shiralizadeh Dezfuli

1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
FRFarzaneh Rostamzadeh
Farzaneh Rostamzadeh
MSMitra Shadkam-Farrokhi
Mitra Shadkam-Farrokhi
SJSaeideh Jafarinejad-Farsangi
Saeideh Jafarinejad-Farsangi
HNHamid Najafipour
Hamid Najafipour
ZAZeinab Ansari-Asl
Zeinab Ansari-Asl
MYMahboobeh Yeganeh-Hajahmadi
Mahboobeh Yeganeh-Hajahmadi
Introduction. The biocompatibility and potential application of graphene‐based nanomaterials in biomedicine have been documented. The effects of polyethylene glycol‐graphene quantum dots (GQDs‐PEG) on cardiac function in rats with myocardial infarction (MI) were examined. Methods. Wistar rats were randomly assigned to two main groups, each consisting of sham‐Veh., MI‐Veh., and MI+GQDs‐PEG at doses of 5, 10, and 20 mg/kg. MI was induced by the closure of the left anterior descending (LAD) coronary artery. After MI, GQDs‐PEG were injected at different doses IP every other day for two weeks. In the end, hemodynamic and heart contractility indices were assessed. The levels of myocardial MDA (malondialdehyde), SOD (superoxide dismutase), GPX (glutathione peroxidase), and TAC (total antioxidant capacity) were measured by the ELISA method. The serum ALP, ALT, AST, creatinine, and urea levels were measured using the photometric method. The infarct size was assessed by TTC staining. Results. GQDs‐PEG decreased the infarct size at doses of 10 and 20 mg/kg and recovered the MI‐induced reductions of +dp/dt max and ‐dp/dt max in the study groups. GQDs‐PEG normalized systolic blood pressure and left ventricular systolic pressure reduction at the dose of 20 mg/kg in the MI group. Heart SOD, GPX, and TAC increased in the GQDs‐PEG 10 and 20 groups. Almost no signs of toxic effects due to GQDs‐PEG administration were observed on the liver and kidneys. Conclusions. The results provided clear evidence that GQDs‐PEG improve cardiac performance and hemodynamic parameters in rats with MI by reducing oxidative stress. GQDs‐PEG is proposed as a therapeutic target for the treatment of MI.

28 January 2022 in Non-coding RNA Research
Verified
Journal Article
Open access
SRSoodeh Rajabi
Soodeh Rajabi
HNHamid Najafipour
Hamid Najafipour
MSMozhgan Sheikholeslami
Mozhgan Sheikholeslami
SJSaeideh Jafarinejad-Farsangi
Saeideh Jafarinejad-Farsangi
ABAhmad Beik
Ahmad Beik
ZKZahra Miri Karam
Zahra Miri Karam
Non-coding RNAs, including long non-coding RNAs (lncRNAs) and microRNAs (miRNAs), play critical roles in the pathogenesis and progression of pulmonary artery hypertension (PAH). LncRNA H19, myocardial infarction-associated transcript (MIAT), miR-29a, and miR-33a have been suggested as potential targets for treating arterial hypertension. We explored the expression pattern of non-coding RNAs H19, MIAT, miR-29a, and miR-33a in monocrotaline (MCT)-induced PAH rats. Moreover, we investigated whether perillyl alcohol (PA) and quercetin (QS), two plant derivatives with beneficial effects on PAH-induced abnormalities, act through regulating the expression of these non-coding RNAs. Male Wistar rats (n = 30) were divided into five groups. MCT (60 mg/kg) was injected subcutaneously to induce PAH. PA (50 mg/kg daily) and QS (30 mg/kg daily) were administered three weeks after induction of PAH. H&E staining and qRT-PCR were performed to assess arteriole wall thickness and gene expression, respectively. Right ventricular systolic pressure (RVSP) and right ventricular hypertrophy (RVH) increased in MCT and MCT + Veh. groups compared to the control group (in both P < 0.001). QS and PA decreased RVSP and RVH significantly. Wall thickness and fibrosis score in the MCT group (score 3) increased compared to the control group (score 0). PA and QS ameliorated wall thickness and fibrosis to score 1 (mild). Also, the expression of miR-29a and miR-33a decreased in the PAH group (in both, P < 0.001). Treatment with PA and QS decreased the expression of H19 (P < 0.001) and MIAT (P < 0.01) and increased the expression of miR-29a (P < 0.01) and miR-33a significantly (P < 0.05 for QS and P < 0.001 for PA). The beneficial effects of PA and QS on PAH-induced abnormalities were exerted through returning the dysregulated expression of H19, MIAT, miR-29a, and miR-33a to normal levels in rats with MTC-induced PAH. This study emphasized the therapeutic potential of PA and QS in PAH. However, more detailed investigations are needed to clarify the underlying molecular mechanisms.

23 February 2024 in Gene
Verified
Journal Article
Closed access
MFMohammad Mojtaba Farazi
Mohammad Mojtaba Farazi
FRFarzaneh Rostamzadeh
Farzaneh Rostamzadeh
SJSaeideh Jafarinejad-Farsangi
Saeideh Jafarinejad-Farsangi
MJMaryam Moazam Jazi
Maryam Moazam Jazi
EJElham Jafari
Elham Jafari
SGSedigheh Gharbi
Sedigheh Gharbi

17 June 2021 in Biomedical Materials
Verified
Journal Article
Closed access
PDF file
SJSaeideh Jafarinejad-Farsangi
Saeideh Jafarinejad-Farsangi
MHMahnaz Sadat Hashemi
Mahnaz Sadat Hashemi
SRSeyede Elmira Yazdi Rouholamini
Seyede Elmira Yazdi Rouholamini
SGSedigheh Gharbi
Sedigheh Gharbi
ZAZeinab Ansari-Asl
Zeinab Ansari-Asl
MSMariam Shahrokhi-Farjah
Mariam Shahrokhi-Farjah
Elimination of tumor cells is still a therapeutic challenge for breast cancer (BC) in men and women. Mammospheres serve as valuable in vitro tools for evaluating tumor behavior and sensitivity to anticancer treatments. Graphene nanosheets with unique physicochemical properties have been considered as potential biomedical approaches for drug delivery, bioimaging, and therapy. Graphene oxide (GO) and graphene quantum dots (GQDs) are suitable nanocarriers for hydrophobic and low bioaccessible anti-tumor materials like curcumin. Despite extensive studies on the potential application of graphene nanosheets in medicine, our knowledge of how different cells function and respond to these nanoparticles remains limited. Here, we evaluated cell death in mammospheres from MCF-7 and primary tumor cells in response to curcumin loaded on graphene nanosheets. Mammospheres were exposed to graphene oxide-curcumin (GO-Cur) and graphene quantum dots-curcumin (GQDs-Cur), and the incidence of cell death was evaluated by Hoechst 33342/propidium iodide double staining and flow cytometry. Besides, the expression of miR-21, miR-29a, Bax, and Bcl-2 genes were assessed using RT-qPCR. We observed, GO, and GQDs had no cytotoxic effect on Kerman male breast cancer/71 (KMBC/71) and MCF-7 tumor cells, while curcumin induced death in more than 50% of tumor cells. GO-Cur and GQDs-Cur synergistically enhanced anti-tumor activity of curcumin. Moreover, GQDs-Cur induced cell death in almost all cells of KMBC/71 mammospheres (99%; p < 0.0001). In contrast, GO-Cur induced cell death in only 21% of MCF-7 mammosphere cells ( p < 0.0001). Also, the expression pattern of miR-21, miR-29a, and Bax/Bcl-2 ratio in KMBC/71 and MCF-7 mammospheres was different in response to GO-Cur and GQDs-Cur. Although KMBC/71 and MCF-7 tumor cells had similar clinical features and displayed similar responses to curcumin, more investigations are needed to clarify the detailed molecular mechanisms underlying observed differences in response to GO-Cur and GQDs-Cur.